PIONEERING PERSONALIZED MEDICINE

ChemoTox is a pharmacogenetic test that delivers guidelines to chemotherapy dosage to minimize the risk of side effects.

And it's all done with a simple swab.Results in 3-5 days.

Over 9% of breast cancer patients are admitted to the hospital due to adverse reactions of chemotherapy.1

Studies show that 3 in 4 cancer patients will not respond to a given Oncology medication.2

Over 68% of patients receiving chemotherapy will suffer chemotherapy induced peripheral neuropathy within the first 30 days of treatment.3

$11.1 billion is spent on supportive care treatments, which help with the side effects of chemotherapy.4

ChemoTox easy to interpret reports empower physicians with actionable genetic information to customize chemotherapy dosage unique to each patient. With 3-5 days turnaround time, patients are likely to be on the right medication at the right dose more quickly.

One simple, non-invasive test gives you fast results that can dramatically improve your patient's quality of life.

ChemoTox is empowered by evidence-based medicine.

“Using ChemoTox for evaluating potential toxicities in chemotherapy will assist clinicians in either choosing less toxic chemotherapy or making dose adjustments upfront to avoid grade 3 and 4 toxicities.”

The insights provided by patients genetic information is now within your reach. Alpha Genomix is committed to finding affordable solutions for all patients. For further details, download our billing guide.